123 related articles for article (PubMed ID: 1716573)
1. Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes.
Maggi CA; Patacchini R; Feng DM; Folkers K
Eur J Pharmacol; 1991 Jun; 199(1):127-9. PubMed ID: 1716573
[TBL] [Abstract][Full Text] [Related]
2. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological assessment of spantide II analogues.
Wang ZY; Feng DM; Wang YL; Tung SR; Wong K; Strichartz GR; Folkers K; Håkanson R
Eur J Pharmacol; 1994 Aug; 260(2-3):121-8. PubMed ID: 7527343
[TBL] [Abstract][Full Text] [Related]
4. Activity of SR 142801 at peripheral tachykinin receptors.
Patacchini R; Barthò L; Holzer P; Maggi CA
Eur J Pharmacol; 1995 May; 278(1):17-25. PubMed ID: 7545122
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological studies of tachykinin receptors mediating contraction of isolated airway smooth muscle.
Buckner CK; Ghanekar SV; Kays JS; Krell RD; Fishleder RI; Will JA; Vann JM
Ann N Y Acad Sci; 1991; 629():340-58. PubMed ID: 1719852
[No Abstract] [Full Text] [Related]
6. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
[TBL] [Abstract][Full Text] [Related]
7. Possible existence of a new tachykinin receptor subtype in the guinea pig ileum.
Petitet F; Saffroy M; Torrens Y; Lavielle S; Chassaing G; Loeuillet D; Glowinski J; Beaujouan JC
Peptides; 1992; 13(2):383-8. PubMed ID: 1384010
[TBL] [Abstract][Full Text] [Related]
8. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
[TBL] [Abstract][Full Text] [Related]
10. A synthetic glycopeptide of substance P analogue (SP6-11) with enhanced NK-1 receptor specificity.
Haro I; Busquets MA; Torres JL; Valencia G; Garcia-Anton JM; Reig F
J Pharm Sci; 1990 Jan; 79(1):74-6. PubMed ID: 1690289
[TBL] [Abstract][Full Text] [Related]
11. Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea.
Ireland SJ; Bailey F; Cook A; Hagan RM; Jordan CC; Stephens-Smith ML
Br J Pharmacol; 1991 Jun; 103(2):1463-9. PubMed ID: 1653074
[TBL] [Abstract][Full Text] [Related]
12. A pharmacological study with substance K: evidence for multiple types of tachykinin receptors.
Hunter JC; Maggio JE
Eur J Pharmacol; 1984 Oct; 105(1-2):149-53. PubMed ID: 6208041
[TBL] [Abstract][Full Text] [Related]
13. Tachykinin receptors in the guinea-pig isolated bronchi.
Maggi CA; Patacchini R; Quartara L; Rovero P; Santicioli P
Eur J Pharmacol; 1991 May; 197(2-3):167-74. PubMed ID: 1717290
[TBL] [Abstract][Full Text] [Related]
14. Actinomycin D is a competitive and selective antagonist at NK2 tachykinin receptors.
Patacchini R; Astolfi M; Brown MC; Maggi CA
Neuropeptides; 1991 Oct; 20(2):109-14. PubMed ID: 1665895
[TBL] [Abstract][Full Text] [Related]
15. Comparison of spantide II and CP-96,345 for blockade of tachykinin-evoked contractions of smooth muscle.
Håkanson R; Wang ZY; Folkers K
Biochem Biophys Res Commun; 1991 Jul; 178(1):297-301. PubMed ID: 1712587
[TBL] [Abstract][Full Text] [Related]
16. Evidence for neurokinin-3 receptor-mediated tachykinin release in the guinea-pig ileum.
Guard S; Watson SP
Eur J Pharmacol; 1987 Dec; 144(3):409-12. PubMed ID: 2450037
[TBL] [Abstract][Full Text] [Related]
17. Substance P (NK-1 receptor) antagonists: in vivo and in vitro activities in rats and guinea pigs.
Rouissi N; Claing A; Nicolau M; Jukic D; D'Orléans-Juste P; Regoli D
Life Sci; 1993; 52(13):1141-7. PubMed ID: 7680744
[TBL] [Abstract][Full Text] [Related]
18. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
Hall JM; Flowers JM; Morton IK
Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
[TBL] [Abstract][Full Text] [Related]
19. A potent and selective agonist for NK-2 tachykinin receptor.
Rovero P; Pestellini V; Patacchini R; Giuliani S; Santicioli P; Maggi CA; Meli A; Giachetti A
Peptides; 1989; 10(3):593-5. PubMed ID: 2550911
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.
Guard S; Watson SP; Maggio JE; Too HP; Watling KJ
Br J Pharmacol; 1990 Apr; 99(4):767-73. PubMed ID: 1694464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
